- decreased muscle cell glucose uptake / MGI
- decreased hematocrit / MGI
- hemolytic anemia / MGI
- low mean erythrocyte cell number / MGI
- reticulocytosis / MGI
- abnormal erythrocyte osmotic lysis / MGI
- increased spleen weight / MGI
- abnormal circulating hormone level / MGI
- decreased mean corpuscular hemoglobin / MGI
- increased red blood cell distribution width / MGI
129S2-Prkaa1tm1Sbj/Orl
Status | Available to order |
EMMA ID | EM:02139 |
Citation information | RRID:IMSR_EM:02139 Research Resource Identifiers (RRID) are persistent unique ID numbers assigned to help researchers cite key resources (e.g. antibodies, model organisms and software projects) in the biomedical literature to improve transparency and reproducibility in research. See https://www.rrids.org/ for more information. |
International strain name | 129S2-Prkaa1tm1Sbj/Orl |
Alternative name | AMPKalpha1 knockout |
Strain type | Targeted Mutant Strains : Knock-out |
Allele/Transgene symbol | Prkaa1tm1Sbj |
Gene/Transgene symbol | Prkaa1 |
Information from provider
Provider | Benoit Viollet |
Provider affiliation | INSERMU567, CNRS UMR8401, universite Paris 5, Institut Cochin |
Genetic information | Sequence encoding amino acids 97 through 157, which make up a portion of the catalytic domain, was replaced with an IRES-betageo cassette inserted by homologous recombination. |
Phenotypic information | Analysis in progress. No defect in glucose homoeostasis was observed in AMPKalpha1 (Prkaa1) -/- mice. |
References |
|
Information from EMMA
Archiving centre | Institut de Transgenose, INTRAGENE, Orléans, France |
Disease and phenotype information
MGI phenotypes (allele matching)
MGI phenotypes (gene matching)
- decreased hematocrit / MGI
- hemolytic anemia / MGI
- low mean erythrocyte cell number / MGI
- reticulocytosis / MGI
- abnormal erythrocyte osmotic lysis / MGI
- increased spleen weight / MGI
- abnormal circulating hormone level / MGI
- decreased mean corpuscular hemoglobin / MGI
- increased red blood cell distribution width / MGI
- decreased muscle cell glucose uptake / MGI
Literature references
- Knockout of the alpha2 but not alpha1 5'-AMP-activated protein kinase isoform abolishes 5-aminoimidazole-4-carboxamide-1-beta-4-ribofuranosidebut not contraction-induced glucose uptake in skeletal muscle.;Jørgensen Sebastian B, Viollet Benoit, Andreelli Fabrizio, Frøsig Christian, Birk Jesper B, Schjerling Peter, Vaulont Sophie, Richter Erik A, Wojtaszewski Jørgen F P, ;2004;The Journal of biological chemistry;279;1070-9; 14573616
- Anti-lipolytic action of AMP-activated protein kinase in rodent adipocytes.;Daval Marie, Diot-Dupuy Francine, Bazin Raymond, Hainault Isabelle, Viollet Benoît, Vaulont Sophie, Hajduch Eric, Ferré Pascal, Foufelle Fabienne, ;2005;The Journal of biological chemistry;280;25250-7; 15878856
- Effects of alpha-AMPK knockout on exercise-induced gene activation in mouse skeletal muscle.;Jørgensen Sebastian B, Wojtaszewski Jørgen F P, Viollet Benoit, Andreelli Fabrizio, Birk Jesper B, Hellsten Ylva, Schjerling Peter, Vaulont Sophie, Neufer P Darrell, Richter Erik A, Pilegaard Henriette, ;2005;FASEB journal : official publication of the Federation of American Societies for Experimental Biology;19;1146-8; 15878932
- Understanding the molecular basis of the interaction between NDPK-A and AMPK alpha 1.;Crawford Russell M, Treharne Kate J, Arnaud-Dabernat Sandrine, Daniel Jean-Yves, Foretz Marc, Viollet Benoit, Mehta Anil, ;2006;Molecular and cellular biology;26;5921-31; 16847342
- Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation.;Dentin Renaud, Benhamed Fadila, Pégorier Jean-Paul, Foufelle Fabienne, Viollet Benoit, Vaulont Sophie, Girard Jean, Postic Catherine, ;2005;The Journal of clinical investigation;115;2843-54; 16184193
- Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase.;Davis Bradley J, Xie Zhonglin, Viollet Benoit, Zou Ming-Hui, ;2006;Diabetes;55;496-505; 16443786
Information on how we integrate external resources can be found here
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).